ScholarGate
어시스턴트

방법 비교

선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.

EORTC QLQ-LC13: 폐암에서의 삶의 질×EORTC QLQ-CX24: 자궁경부암의 삶의 질×
분야종양학종양학
계열Process / pipelineProcess / pipeline
기원 연도19942006
창시자Bergman, B., et al. (EORTC Quality of Life Group)Greimel, E. R., et al. (EORTC Quality of Life Group)
유형Self-report questionnaireSelf-report questionnaire
원전Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗Greimel, E. R., Kuljanic Vlasic, K., Zwahlen, D., Rand, K., Heitz, U., Havsteen, H., et al. (2006). The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Acta Oncol, 45(3), 344–351. DOI ↗
별칭QLQ-LC13QLQ-CX24
관련55
요약The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.The EORTC QLQ-CX24 is a 24-item cervical-cancer-specific module designed to complement the EORTC QLQ-C30 core questionnaire. Developed by Greimel et al. in 2006, it measures sexual/vaginal function, body image, lymphedema, neuropathy, and gastrointestinal symptoms specific to cervical cancer and its treatments. It is the standard cervical cancer-specific QoL instrument in international oncology research.
ScholarGate데이터셋
  1. v1
  2. 2 출처
  3. PUBLISHED
  1. v1
  2. 2 출처
  3. PUBLISHED

검색으로 이동 슬라이드 다운로드

ScholarGate방법 비교: EORTC QLQ-LC13 · EORTC QLQ-CX24. 2026-06-19에 다음에서 검색함: https://scholargate.app/ko/compare